Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on the company's proprietary technology. The products are sold under separate trademarks and collaboration on product development is done together with other players in the field. The company is based in Uppsala.
| Type | Document | Details | Language | Filing Date | File Number |
|---|
Access comprehensive European stock market filings data through a single, powerful API.
1,5M+
filings covered
18
European countries
30min
max latency
1 API
for all filings
Limited spots available. Join now!
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
ABAS
Sector
Country
Sweden
ISIN
SE0018588659
Founded
ABAS Protect develops, manufactures, and sells area protection primarily to industry, and public administrations, but also to private individuals. The …
ABERA
Sector
Country
Sweden
ISIN
SE0015245097
Founded
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed …
ABI
Sector
Country
Sweden
ISIN
SE0006091476
Founded
Igrene is an exploration company with a main focus on gas and oil. The largest part of the business activity …
None
Sector
Country
Russia
ISIN
RU000A0JS5T7
Founded
Abrau-Durso is a prominent Russian producer of sparkling wine , which uses traditional methods to create their products. The company …
